Is It Time to Cross the Pillars of Evidence in Favor of Segmentectomies in Early-Stage Non-Small Cell Lung Cancer?-Reference-Cited by-同舟云学术

Is It Time to Cross the Pillars of Evidence in Favor of Segmentectomies in Early-Stage Non-Small Cell Lung Cancer?

Published:2023-03-27 Issue:7 Volume:15 Page:1993
ISSN:2072-6694
Container-title:Cancers
language:en
Short-container-title:Cancers

Author:

Bertolaccini Luca¹^ORCID,Spaggiari Lorenzo¹²

Affiliation:

1. Department of Thoracic Surgery, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy

2. Department of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, Italy

Abstract

In the debate on lobectomy versus segmentectomy for the treatment of early-stage non-small cell lung cancer (NSCLC), currently, we have reached two pillars of knowledge, like Jachim and Boaz, which have encompassed the actual boundary of the literature published up until now [...]

Funder

Italian Ministry of Health

Publisher

MDPI AG

Subject

Cancer Research,Oncology

Link

https://www.mdpi.com/2072-6694/15/7/1993/pdf

Reference16 articles.

1. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group;Ginsberg;Ann. Thorac. Surg.,1995

2. Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): A multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial;Saji;Lancet,2022

3. Lobar or Sublobar Resection for Peripheral Stage IA Non-Small-Cell Lung Cancer;Altorki;N. Engl. J. Med.,2023